Attenua
ClosedAttenua.com is for sale | HugeDomains
United States · Founded 2015 · $35.0M raised
- Founded
- 2015
- Business Model
- B2B
- Website
- attenua.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Series AApr 2018
- Rounds
- 1
About
Attenua is a clinical-stage biotechnology company that developed novel medicines for patients with chronic respiratory disorders such as chronic cough. Its 2018 Series A announcement said no new cough drugs had been approved in the U.S. since 1958 and positioned lead candidate ATA-101 as a non-narcotic therapy targeting a new mechanism for chronic cough, headed to Phase 2. The company was based in Mountain View and later coverage described the program as having failed; attenua.com is listed for sale.
Summary
Attenua is a Biotech company based in United States, founded in 2015. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Apr 2018. Investors include Omega Funds, OrbiMed and Redmile Group.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2018
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/attenua"><img src="https://indexed.vc/api/badge/company/attenua" alt="Attenua on Indexed.vc" width="260" height="76" /></a>